Upgrade to SI Premium - Free Trial

Nkarta (NKTX) Surges 55% After Announcing Positive Preliminary Dose Finding Data for Two Lead Engineered Natural Killer Cell Programs

April 25, 2022 7:12 AM
Nkarta (NASDAQ: NKTX) Surges ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Hot FDA News Momentum Movers Trader Talk

Next Articles